Tarsus Pharmaceuticals, Inc. (TARS)
75.69
-0.27
(-0.36%)
USD |
NASDAQ |
Sep 25, 16:00
75.66
-0.02
(-0.03%)
After-Hours: 19:59
Tarsus Pharmaceuticals Price to Book Value : 9.446 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 9.446 |
| September 24, 2026 | 9.480 |
| September 23, 2026 | 9.271 |
| September 22, 2026 | 9.619 |
| September 21, 2026 | 9.667 |
| September 18, 2026 | 9.745 |
| September 17, 2026 | 9.863 |
| September 16, 2026 | 9.689 |
| September 15, 2026 | 9.763 |
| September 14, 2026 | 9.978 |
| September 11, 2026 | 9.898 |
| September 10, 2026 | 10.12 |
| September 09, 2026 | 10.33 |
| September 08, 2026 | 10.88 |
| September 04, 2026 | 11.33 |
| September 03, 2026 | 10.38 |
| September 02, 2026 | 10.33 |
| September 01, 2026 | 9.241 |
| August 31, 2026 | 9.265 |
| August 28, 2026 | 8.956 |
| August 27, 2026 | 8.975 |
| August 26, 2026 | 8.817 |
| August 25, 2026 | 8.917 |
| August 24, 2026 | 9.086 |
| August 21, 2026 | 9.073 |
| Date | Value |
|---|---|
| August 20, 2026 | 8.922 |
| August 19, 2026 | 9.165 |
| August 18, 2026 | 8.864 |
| August 17, 2026 | 8.813 |
| August 14, 2026 | 8.636 |
| August 13, 2026 | 8.596 |
| August 12, 2026 | 8.738 |
| August 11, 2026 | 8.668 |
| August 10, 2026 | 8.456 |
| August 07, 2026 | 8.086 |
| August 06, 2026 | 8.153 |
| August 05, 2026 | 7.649 |
| August 04, 2026 | 7.626 |
| August 03, 2026 | 7.653 |
| July 31, 2026 | 7.368 |
| July 30, 2026 | 7.430 |
| July 29, 2026 | 7.303 |
| July 28, 2026 | 7.357 |
| July 27, 2026 | 7.503 |
| July 24, 2026 | 7.321 |
| July 23, 2026 | 7.311 |
| July 22, 2026 | 7.186 |
| July 21, 2026 | 7.146 |
| July 20, 2026 | 7.020 |
| July 17, 2026 | 7.469 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Bristol Myers Squibb Co. | 5.754 |
| ANI Pharmaceuticals, Inc. | 2.846 |
| Corcept Therapeutics, Inc. | 17.75 |
| Veru, Inc. | 1.526 |
| Johnson & Johnson | 7.687 |
Price to Book Value Related Metrics
| PS Ratio | 5.360 |
| Price to Free Cash Flow | 58.03 |
| Price | 75.69 |
| Earnings Yield | -1.43% |
| Market Cap | 3.275B |